Abbott Laboratories, Usa
Case brief
What is this about?
Competition Commission filed summary of Abbott Laboratories' acquisition of St. Jude Medical, outlining businesses and regulatory status under 2011 Combination Regulations.
What the court decided
A compact analysis
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
SUMMARY
Summary in terms of Regulation 13(1B) of the Competition Commission of India (Procedure in regard to the Transaction of Business relating to Combinations) Regulations, 2011 (as amended)
a) Names of parties of the combination
- Abbott Laboratories ( Abbott ) and St. Jude Medical, Inc. ( SJM ) are the parties to the combination. Along with the parties, two newly incorporated wholly owned subsidiaries of Abbott Laboratories – Vault Merger Sub, LLC and Vault Merger Sub, Inc. – are also parties to the Agreement and Plan of Merger ( Agreement ) executed on 27 April 2016, which governs the terms of Abbott’s acquisition of SJM.
b) Type of the combination
- The proposed combination relates to the acquisition of SJM by Abbott, hereinafter referred to as the Proposed Combination .
c) Area of activity of the parties to the combination
- Abbott is a publicly traded global healthcare corporation devoted to improving life through the development of products and technologies in the healthcare segment.
- Abbott has four principal divisions from which it derives its primary revenue. These are:
Case details
As recorded by the court registry
Similar cases
Judgements on the same questions, provisions and authorities, from every court